Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Nucleolar Protein 1 (NOL1) anticorps

Cet anticorps anti- est un anticorps Lapin Polyclonal détectant dans WB, IF (p) et IHC (p). Adapté pour Humain, Rat et Souris.
N° du produit ABIN1385475

Aperçu rapide pour Nucleolar Protein 1 (NOL1) anticorps (ABIN1385475)

Antigène

Voir toutes Nucleolar Protein 1 (NOL1) Anticorps
Nucleolar Protein 1 (NOL1)

Reactivité

  • 31
  • 21
  • 21
  • 5
  • 5
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Rat, Souris

Hôte

  • 31
  • 1
Lapin

Clonalité

  • 31
  • 1
Polyclonal

Conjugué

  • 11
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Inconjugué

Application

  • 28
  • 12
  • 7
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  •  Réactivité croisée

    Humain, Souris, Rat

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human NOL1

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    IHC-P 1:200-400
    IF(IHC-P) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Date de péremption

    12 months
  • Antigène

    Nucleolar Protein 1 (NOL1)

    Autre désignation

    NOL1

    Sujet

    Synonyms: proliferation Associated Nucleolar Antigen: NOL 1, NUCLEOLAR ANTIGEN p120, NOP2_HUMAN.

    Background: Proliferation-associated nucleolar antigen is expressed in mid G1 phase with peak level during the S phase and a rapid degradation during late mitosis. Its expression in breast carcinoma is correlated with patient prognosis.

    ID gène

    4839
Vous êtes ici:
Chat with us!